MedPath

Found 556472 clinical trials

Sort by:

Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)

Recruiting

Conditions: Primary Biliary Cholangitis (PBC)

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: Hospital Universitario La Paz

Target Recruit Count: 80

Registration Number: NCT07205874

Locations: 🇪🇸
Hospital Universitario La Paz, Madrid, Spain

Prevalence and Determinants of Shoulder Girdle Musculoskeletal Complaints in Geriatric Patients With Diminished Vision

Completed

Conditions: Visual Impairment
Age-Related Macular Degeneration (AMD)
Musculoskeletal Pain
Shoulder Pain
Geriatric Syndrome

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: Beni-Suef University

Target Recruit Count: 100

Registration Number: NCT07206654

Locations: 🇪🇬
Beni Suef University, Banī Suwayf, Beni Suweif Governorate, Egypt

Comparison of Leakage in Endodontically Treated Teeth Obturated With Different Types of Gutta Percha Coatings and Bioceramic Sealer

Not Applicable

Not yet recruiting

Conditions: Leakage Testing

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: Pakistan Institute of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT07205809

Locations: 🇵🇰
School of Dentistry, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Islamabad, Pakistan

Real Life Data From Hypertensive Patients Treated With Renal Denervation in Current Practice in France- French RENal Denervation Registry

Recruiting

Conditions: Hypertension (HTN)

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: University Hospital, Grenoble

Target Recruit Count: 100

Registration Number: NCT07206030

Locations: 🇫🇷
Chu Grenoble Alpes, La Tronche, France, France

The Eplontersen Pregnancy and Lactation Outcomes Study

Not yet recruiting

Conditions: Transthyretin Amyloidosis

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: AstraZeneca

Target Recruit Count: 10

Registration Number: NCT07205666

Effect of Telerehabilitation on Quality of Life, Pain, and Function After Rotator Cuff Surgery

Not Applicable

Completed

Conditions: Rotator Cuff Tears

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: Aysan Yaghoubi

Target Recruit Count: 30

Registration Number: NCT07205094

Locations: Beykent University Hospital, Istanbul, Istanbul, Turkey (Türkiye)

Validation of the Swedish Translation of a Brief Shame Measure, the External and Internal Shame Scale

Not yet recruiting

Conditions: Shame

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: Uppsala University

Target Recruit Count: 450

Registration Number: NCT07206966

Locations: 🇸🇪
Uppsala University Hospital, Uppsala, Sweden

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Not Applicable

Not yet recruiting

Conditions: Breast Cancer

Interventions: Drug: Dato-DXd

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: AstraZeneca

Target Recruit Count: 100

Registration Number: NCT07205822

Locations: 🇪🇸
Research Site, Valencia, Spain

AI-Guided Left Bundle Branch Area Pacing

Not Applicable

Not yet recruiting

Conditions: Heart Failure

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 224

Registration Number: NCT07206602

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

Not Applicable

Not yet recruiting

Conditions: Breast Cancer

Interventions: Drug: JS105
Drug: Dalpiciclib
Drug: Fulvestrant 50 Mg/mL Intramuscular Solution

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd.

Target Recruit Count: 312

Registration Number: NCT07207070

Locations: 🇨🇳
Chinese Acadamy of Medical Sciences and Peking Union Medical College, Beijing, Beijing Municipality, China
🇨🇳
Henan Provincial Cancer Hospital, Zhengzhou, Henan, China

AI-Powered Research

Premium Access

Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)

Prevalence and Determinants of Shoulder Girdle Musculoskeletal Complaints in Geriatric Patients With Diminished Vision

Comparison of Leakage in Endodontically Treated Teeth Obturated With Different Types of Gutta Percha Coatings and Bioceramic Sealer

Real Life Data From Hypertensive Patients Treated With Renal Denervation in Current Practice in France- French RENal Denervation Registry

The Eplontersen Pregnancy and Lactation Outcomes Study

Effect of Telerehabilitation on Quality of Life, Pain, and Function After Rotator Cuff Surgery

Validation of the Swedish Translation of a Brief Shame Measure, the External and Internal Shame Scale

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

AI-Guided Left Bundle Branch Area Pacing

A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

Product

Company

Legal